You can buy or sell SURF and other stocks, options, ETFs, and crypto commission-free!
Surface Oncology, Inc. Common Stock, also called Surface Oncology, is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. Read More The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Expected Nov 12, Pre-Market